| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/08/2014 | CN103494931A Chinese medicine fumigating lotion for treating thrombophlebitis |
| 01/08/2014 | CN103494912A Euryale ferox granules and preparation method thereof |
| 01/08/2014 | CN103494910A Application of Mai junan tablet in control of blood pressure fluctuation |
| 01/08/2014 | CN103494898A Preparation method and application of refined tablet for treating coronary disease |
| 01/08/2014 | CN103494893A Footbath powder capable of resolving toxin with clear coolness |
| 01/08/2014 | CN103494872A Preparation method and application of yufengningxin tablets |
| 01/08/2014 | CN103494868A Application of total saponins of falcate dolichos root leaf in resisting atherosclerosis, regulating blood-lipid and resisting myocardial ischemia |
| 01/08/2014 | CN103494865A Composition of human stem cell and gynostemma pentaphyllum bioactive substances and preparation method thereof |
| 01/08/2014 | CN103494858A Method for enriching total flavonoids in taraxacum mongolicum with macroporous resins |
| 01/08/2014 | CN103494857A Preparation method and application of chest smoothing tablets |
| 01/08/2014 | CN103494852A Method for enriching total flavonoids in herba artemisiae scopariae with macroporous resins |
| 01/08/2014 | CN103494840A Lotion for treating hemorrhoids |
| 01/08/2014 | CN103494825A Application of Kadcoccitones A in preparing medicine treating ischemic brain injury |
| 01/08/2014 | CN103494824A Application of Kadcoccitones A in preparing medicine treating or preventing acute heart failure |
| 01/08/2014 | CN103494820A Nimodipine/ligustrazine double-load PLGA nanoparticles and preparation method thereof |
| 01/08/2014 | CN103494817A Methods and compoistions used for treatment and control of multiple myeloma |
| 01/08/2014 | CN103494794A Medical application of bibenzyl compounds |
| 01/08/2014 | CN103494793A Application of 3,4,5,3',4',5'-hexamethoxy-trans-stilbene in preparing angiogenesis promoting drugs |
| 01/08/2014 | CN103494773A ZL006 liposome and preparation method thereof |
| 01/08/2014 | CN103494206A Preparation process of soft capsule containing peony seed essential oil and peony petal isoflavone |
| 01/08/2014 | CN103494194A Novel formula and production technology of drone, ginseng and pseudo-ginseng capsule product |
| 01/08/2014 | CN103493923A Formula and production method of bitter gourd tea capable of reducing internal heat and reducing blood pressure |
| 01/08/2014 | CN103493799A Improved organ protection, preservation and recovery |
| 01/08/2014 | CN102908363B Deproteinized calf blood extract and preparation process thereof |
| 01/08/2014 | CN102885971B Chinese herbal medicine decoction for treating hemorrhoids and preparation method thereof |
| 01/08/2014 | CN102784240B Method for preparing traditional Tibetan medicine for treating coronary disease and stenocardia |
| 01/08/2014 | CN102755557B Herbal medicine for relieving piles symptoms |
| 01/08/2014 | CN102698201B Chinese medicine for treating varicocele |
| 01/08/2014 | CN102670969B Traditional Chinese medicine oral liquid for treating arrhythmia and preparation method |
| 01/08/2014 | CN102660523B Low-immunogenicity lumbrukinase, preparation method and application thereof |
| 01/08/2014 | CN102552399B Traditional Chinese medicinal composition for clearing heat and calming liver and preparation method thereof |
| 01/08/2014 | CN102552200B Felodipine sustained-release tablets |
| 01/08/2014 | CN102423347B Traditional Chinese drug composition for treating heart failure, and application thereof |
| 01/08/2014 | CN102382102B Amide compound |
| 01/08/2014 | CN102357201B Traditional Chinese medicine composition for treating venous injury, and preparation method and application thereof |
| 01/08/2014 | CN102264366B Composition containing sesamins and epigallocatechin gallate |
| 01/08/2014 | CN101903349B 4-(4-pyridinyl)-benzamides and application thereof as ROCK activity modulators |
| 01/08/2014 | CN101426772B Benzotriazine inhibitors of kinases |
| 01/07/2014 | US8623881 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 01/07/2014 | US8623833 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 01/07/2014 | US8623823 Methods for treatment of stroke or cerebrovascular accidents using an ETB receptor agonist |
| 01/07/2014 | US8623406 Stable pharmaceutical composition and methods of using same |
| 01/07/2014 | US8623373 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 01/07/2014 | CA2542504C Lipids containing omega-3 and omega-6 fatty acids |
| 01/07/2014 | CA2497216C Local vascular delivery of cladribine in combination with rapamycin to prevent restenosis following vascular injury |
| 01/07/2014 | CA2461372C Dna sequences for human angiogenesis genes |
| 01/07/2014 | CA2453967C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/03/2014 | WO2014004902A2 Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof |
| 01/03/2014 | WO2014003844A1 Biocompatible polyacrylate compositions and methods of use |
| 01/03/2014 | WO2014003678A1 Pharmaceutical compositions comprising ambrisentan and solid dispersion particles containing tadalafil |
| 01/03/2014 | WO2014003677A1 Pharmaceutical compositions comprising solid dispersion particles containing tadalafil |
| 01/03/2014 | WO2014003531A1 Nasal vaccine against the development of atherosclerosis disease and fatty liver |
| 01/03/2014 | WO2014003154A1 Agent for preventing deterioration in vascular endothelial function or improving vascular endothelial function |
| 01/03/2014 | WO2014002851A1 Solid pharmaceutical tablet and method for producing same |
| 01/03/2014 | WO2014002571A1 Angiotensin-converting-enzyme inhibiting dipeptide |
| 01/03/2014 | WO2014002057A1 Pyrrolidine derivatives and their use as complement pathway modulators |
| 01/03/2014 | WO2014002054A1 Pyrrolidine derivatives and their use as complement pathway modulators |
| 01/03/2014 | WO2014002053A1 Pyrrolidine derivatives and their use as complement pathway modulators |
| 01/03/2014 | WO2014002052A1 Pyrrolidine derivatives and their use as complement pathway modulators |
| 01/03/2014 | WO2014001802A1 2-aminopyrazine derivatives as csf-1 r kinase inhibitors |
| 01/03/2014 | WO2014001589A1 Fat binder obtained from biomass resulting from beer production |
| 01/03/2014 | WO2014001183A1 Pharmaceutical composition having synergistic action of direct catalase inhibitors and modulators of no metabolism or of extracellular superoxide anion production which lead to catalase destruction |
| 01/03/2014 | WO2014000629A1 Hexahydropentaleno derivatives, preparation method and use in medicine thereof |
| 01/03/2014 | WO2014000119A1 Anti-tachyarrhythmia formulation and preparation method thereof |
| 01/03/2014 | WO2013165921A3 Therapeutic use of chardonnay seed products |
| 01/03/2014 | CA2877953A1 Agent for preventing deterioration in vascular endothelial function or improving vascular endothelial function |
| 01/03/2014 | CA2877514A1 Methods of reducing the risk of a cardiovascular event in a subject on statin therapy |
| 01/03/2014 | CA2877449A1 2-aminopyrazine derivatives as csf-1 r kinase inhibitors |
| 01/03/2014 | CA2876993A1 Pyrrolidine derivatives and their use as complement pathway modulators |
| 01/03/2014 | CA2876949A1 Fat binder obtained from brewing process biomass |
| 01/03/2014 | CA2876703A1 Oxabicycloheptanes and oxabicycloheptenes for the treatment of reperfusion injury |
| 01/02/2014 | US20140005402 Crystalline forms of pitavastatin calcium |
| 01/02/2014 | US20140005171 Ophthalmic Ointment Composition Comprising a Drug, an Ointment Base and a Solubilizing/Dispersing Agent |
| 01/02/2014 | US20140004603 Urocortin-iii and uses thereof |
| 01/02/2014 | US20140004095 Albumin fusion proteins |
| 01/01/2014 | EP2679586A1 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same |
| 01/01/2014 | EP2679233A1 A preparation used for anti-tachyarrhythmia and its preparation method |
| 01/01/2014 | EP2679227A1 Nanoparticle containing prostaglandin i2 derivative |
| 01/01/2014 | EP2679225A1 Pharmaceutical compound with synergistic effect of direct catalase inhibitors and modulators for NO metabolism which lead to catalase destruction or extracellular superoxide anion production |
| 01/01/2014 | EP2679220A1 Controlled porous osmotic pump tablet and the preparation method thereof |
| 01/01/2014 | EP2678025A1 Therapeutic method for treating congestive heart failure |
| 01/01/2014 | EP2678017A2 Asymmetric ureas and medical uses thereof |
| 01/01/2014 | EP2678006A1 Packaging of solid pharmaceutical preparations containing the active substance glyceryl trinitrate |
| 01/01/2014 | EP2678000A1 Stabilized granules containing glyceryl trinitrate |
| 01/01/2014 | EP2133330B1 Atropisomer of pyrrole derivative |
| 01/01/2014 | CN103492392A Thieno [2, 3 -d] pyrimidine derivatives and their use to treat arrhythmia |
| 01/01/2014 | CN103491973A Infant formula for use in the prevention of cardiovascular diseases |
| 01/01/2014 | CN103484519A Wheat protein peptide, preparation method and application thereof |
| 01/01/2014 | CN103484518A Walnut protein peptide, preparation method and application thereof |
| 01/01/2014 | CN103484517A Camellia seed protein peptide, preparation method and application thereof |
| 01/01/2014 | CN103484336A Formula and production method of pilose antler wine for invigorating blood circulation and nourishing heart |
| 01/01/2014 | CN103483487A Novel structure product, preparation method and use of styrenic resin |
| 01/01/2014 | CN103483458A New technology for extracting polysaccharides from Lentinus edodes stems |
| 01/01/2014 | CN103483439A Alpha O-superfamily conotoxin peptide, and medicinal composition and use thereof |
| 01/01/2014 | CN103483418A DPP-IV inhibiting polypeptide and application thereof |
| 01/01/2014 | CN103483334A Crystal form of penehyclidine hydrochloride racemic mixture II and preparation method thereof |
| 01/01/2014 | CN103483333A Crystal form of penehyclidine hydrochloride racemic mixture I and preparation method thereof |
| 01/01/2014 | CN103483282A Phenyl-substituted triazole amide compounds and application |
| 01/01/2014 | CN103483281A Triazole amide compound and preparing method and antidiabetic function thereof |
| 01/01/2014 | CN103483226A Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto |